NewKerala.com

Indian Pharma's Russian Expansion: Why Local Production Could Reshape Markets

Indian pharmaceutical companies are actively exploring opportunities to establish production facilities across various Russian regions. This growing interest was highlighted during the recent Russia-India business forum in Kazan. Both countries see complementary strengths, with Russia offering technological assets and India providing skilled workforce and industry expertise. The collaboration aims to strengthen cooperation in pharmaceuticals, agriculture, and renewable energy sectors.

Key Points: Indian Pharma Companies Plan Production Facilities in Russia

  • Indian pharma companies negotiating joint production facilities across Russian regions
  • Russia's engineering holding to manufacture 120 railway trains in India
  • Plans for largest API production center in Russia to ensure self-sufficiency
  • Complementary strengths: Russia's technology assets with India's skilled workforce
  • Tatarstan Investment Agency emphasizes involving enterprises in bilateral agreements
  • Business forum highlights cooperation in pharma, agriculture, and renewable energy
2 min read

Indian firms look to localise pharma production in Russia

Indian pharmaceutical firms explore local production in Russia amid growing bilateral cooperation, with plans for joint ventures and API manufacturing centers.

"India supplies a significant share of generics and active pharmaceutical ingredients to Russia, and we plan to establish the largest API production centre in Russia - Sammy Kotwani"

Moscow, October 17

The Russian market is attracting growing interest from Indian pharmaceutical companies exploring opportunities to establish production facilities across various regions of the country. This was announced by Moscow Government Minister and Head of the Department for External Economic and International Relations, Sergey Cheremin, during the "TIME: Russia-India. Mutual Efficiency" forum.

"At present, productive negotiations are underway with a Russian pharmaceutical company on the establishment of joint production in India. Indian pharmaceutical firms are actively exploring the possibility of localisation in different regions of the Russian Federation. We hope that in the near future Indian engineering enterprises and industrial groups will also turn their attention to the Russian market," Cheremin said in an exclusive comment to TV BRICS.

He cited the example of a major agreement under which Russia's largest engineering holding will manufacture 120 new-generation railway trains in India -- a move he said confirms the competitiveness of Russian engineering and demonstrates the country's ability to succeed in Asian markets, as reported by TV BRICS.

Head of the Tatarstan Investment Development Agency, Taliya Minullina, emphasised the importance of involving enterprises and sectoral bodies in implementing bilateral agreements, highlighting that this approach makes joint production particularly promising.

Indian Business Alliance President Sammy Kotwani noted that Russia and India have complementary strengths. "Russia has natural and technological assets, while India offers a skilled workforce and expertise in key industries," he said, adding that this synergy could strengthen cooperation in pharmaceuticals, agriculture, textiles, renewable energy, and the creative industries.

"India supplies a significant share of generics and active pharmaceutical ingredients (API) to Russia, and we plan to establish the largest API production centre in Russia to ensure pharmaceutical self-sufficiency," Kotwani added.

The first "TIME: Russia-India. Mutual Efficiency" Business Forum was held in Kazan on October 8-9 with informational support from TV BRICS, alongside the BRICS Global Media Tour organised by the network and Tatmedia.

- ANI

Share this article:

Reader Comments

R
Rohit P
While this partnership sounds promising, I hope our companies maintain the same quality standards abroad as they do in India. We've built a strong reputation in generics globally.
A
Arjun K
Win-win situation! Russia gets our pharma expertise and we get access to their market. The railway trains deal shows this partnership goes beyond just medicines. More such collaborations please!
S
Sarah B
As someone working in pharma exports, this makes perfect business sense. Russian market has huge potential and local production will reduce costs and improve supply chain reliability.
V
Vikram M
Great strategic move! This will help counter Chinese dominance in pharma raw materials. India-Russia partnership has always been strong, and now it's expanding to new sectors. Jai Hind!
M
Michael C
I appreciate the balanced approach - joint production in India and localization in Russia. This shows mature economic diplomacy that benefits both nations equally.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50